Drug-Eluting Stent Enthusiasts Concede CABG Revenue Loss For Hospitals

Cardiovascular interventionalists and analysts agree that 10-20% of U.S. coronary revascularization procedures will shift each year from coronary artery bypass graft (CABG) to drug-eluting stents